The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 255K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, T.
Right arrow Articles by Kurosaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, T.
Right arrow Articles by Kurosaki, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/2/641/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 4, February 21, 2000 641-650


Original Article

Cbl Suppresses B Cell Receptor–mediated Phospholipase C (PLC)-{gamma}2 Activation by Regulating B Cell Linker Protein–PLC-{gamma}2 Binding

Tomoharu Yasudaa, Akito Maedab, Mari Kurosakib, Tohru Tezukaa, Katsunori Hironakaa, Tadashi Yamamotoa, and Tomohiro Kurosakib
a From the Department of Oncology, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan
b Department of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570-8506, Japan

Correspondence to: Tomohiro Kurosaki, Dept. of Molecular Genetics, Institute for Liver Research, Kansai Medical University, Moriguchi 570-8506, Japan. Tel:81-6-6993-9445 Fax:81-6-6994-6099 E-mail:kurosaki{at}mxr.mesh.ne.jp.

Accumulating evidence indicates that the Cbl protein plays a negative role in immune receptor signaling; however, the mode of Cbl action in B cell receptor (BCR) signaling still remains unclear. DT40 B cells deficient in Cbl showed enhanced BCR-mediated phospholipase C (PLC)-{gamma}2 activation, thereby leading to increased apoptosis. A possible explanation for the involvement of Cbl in PLC-{gamma}2 activation was provided by findings that Cbl interacts via its Src homology 2 (SH2) domain with B cell linker protein (BLNK) after BCR ligation. BLNK is a critical adaptor molecule for PLC-{gamma}2 tyrosine phosphorylation through its binding to the PLC-{gamma}2 SH2 domains. As a consequence of the interaction between Cbl and BLNK, the BCR-induced recruitment of PLC-{gamma}2 to BLNK and the subsequent PLC-{gamma}2 tyrosine phosphorylation were inhibited. Thus, our data suggest that Cbl negatively regulates the PLC-{gamma}2 pathway by inhibiting the association of PLC-{gamma}2 with BLNK.

Key Words: adaptor molecule, antigen receptor, lymphocyte, negative regulator, signaling


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS